Search research articles
Contact Us
Filters
Showing results (241-250 of 266) with videos related to
Page
of 27
Sort By:
Bioorganic & Medicinal Chemistry
|
March 19, 2013
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties
E Jeffrey North, Michael S Scherman, David F Bruhn, et al.
The Journal of Antimicrobial Chemotherapy
|
August 12, 2008
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents
Julian G Hurdle, Robin B Lee, Nageshwar R Budha, et al.
BMC Palliative Care
|
January 28, 2019
"Just too busy living in the moment and surviving": barriers to accessing health care for structurally vulnerable populations at end-of-life
K I Stajduhar, A Mollison, M Giesbrecht, et al.
Bioorganic & Medicinal Chemistry
|
September 22, 2012
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties
Rakesh, David Bruhn, Dora B Madhura, et al.
Lupus
|
October 10, 2019
Implementation and dissemination of an African American popular opinion model to improve lupus awareness: an academic-community partnership
C R Phillip, K Mancera-Cuevas, C Leatherwood, et al.
Bioorganic & Medicinal Chemistry
|
April 24, 2012
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability
Michael S Scherman, Elton J North, Victoria Jones, et al.
International Journal of Systematic and Evolutionary Microbiology
|
August 16, 2017
Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples
Rebecca M Davidson, Mary Ann DeGroote, Jamie L Marola, et al.
Bioorganic & Medicinal Chemistry
|
August 16, 2011
The structure-activity relationship of urea derivatives as anti-tuberculosis agents
Joshua R Brown, Elton J North, Julian G Hurdle, et al.
Plos One
|
February 8, 2014
Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis
Rakesh, David F Bruhn, Michael S Scherman, et al.
Surgery Open Science
|
September 5, 2022
Geographic variation in attitudes regarding management of locally advanced pancreatic cancer
Logan R McNeil, Alex B Blair, Robert W Krell, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 266) with videos related to
Sort By:
Page
of 27
Bioorganic & Medicinal Chemistry
|
March 19, 2013
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties
E Jeffrey North, Michael S Scherman, David F Bruhn, et al.
The Journal of Antimicrobial Chemotherapy
|
August 12, 2008
A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents
Julian G Hurdle, Robin B Lee, Nageshwar R Budha, et al.
BMC Palliative Care
|
January 28, 2019
"Just too busy living in the moment and surviving": barriers to accessing health care for structurally vulnerable populations at end-of-life
K I Stajduhar, A Mollison, M Giesbrecht, et al.
Bioorganic & Medicinal Chemistry
|
September 22, 2012
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties
Rakesh, David Bruhn, Dora B Madhura, et al.
Lupus
|
October 10, 2019
Implementation and dissemination of an African American popular opinion model to improve lupus awareness: an academic-community partnership
C R Phillip, K Mancera-Cuevas, C Leatherwood, et al.
Bioorganic & Medicinal Chemistry
|
April 24, 2012
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability
Michael S Scherman, Elton J North, Victoria Jones, et al.
International Journal of Systematic and Evolutionary Microbiology
|
August 16, 2017
Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples
Rebecca M Davidson, Mary Ann DeGroote, Jamie L Marola, et al.
Bioorganic & Medicinal Chemistry
|
August 16, 2011
The structure-activity relationship of urea derivatives as anti-tuberculosis agents
Joshua R Brown, Elton J North, Julian G Hurdle, et al.
Plos One
|
February 8, 2014
Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis
Rakesh, David F Bruhn, Michael S Scherman, et al.
Surgery Open Science
|
September 5, 2022
Geographic variation in attitudes regarding management of locally advanced pancreatic cancer
Logan R McNeil, Alex B Blair, Robert W Krell, et al.
Page
of 27